Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 292
Last updated 2026-03-06
Summary
This study aims to examine the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular diseases by studying the association between liver fibrosis degree and cardiovascular risk factors. The study would clarify the value and the role of the Coronary calcium score (CAC score) in the screening for coronary disease in this population at high cardiovascular risk.
Conditions
- NAFLD
Sponsors & Collaborators
-
Clinique Pasteur
lead OTHER
Principal Investigators
-
Maeva GUILLAUME, MD · Clinique Pasteur
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-18
- Primary Completion
- 2025-04-30
- Completion
- 2025-04-30
Countries
- France
Study Locations
More Related Trials
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease
NCT03307408 ·Status: UNKNOWN
-
NAFLD Primary Care
NCT04918732 ·Status: RECRUITING ·Phase: NA
-
Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
NCT06119997 ·Status: RECRUITING
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )
NCT05790057 ·Status: UNKNOWN
-
Early Detection of Advanced Fatty Liver Disease
NCT03608748 ·Status: COMPLETED
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study
NCT01306110 ·Status: COMPLETED
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)
NCT04057287 ·Status: RECRUITING
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
NCT04191044 ·Status: UNKNOWN
-
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
NCT01100398 ·Status: COMPLETED
-
Mitochondrial Metabolism and Hepatic Complications of Obesity
NCT03302481 ·Status: WITHDRAWN ·Phase: NA
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
NCT04782050 ·Status: COMPLETED ·Phase: NA
-
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
NCT00844779 ·Status: UNKNOWN
-
Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis
NCT03746210 ·Status: RECRUITING
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease
NCT02422238 ·Status: RECRUITING